




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)
文檔簡介
1、PharmacologyDrugs that Affect the Cardiovascular SystemTopicsElectrophysiologyVaughn-Williams classificationAntihypertensivesHemostatic agentsCardiac FunctionDependent uponAdequate amounts of ATPAdequate amounts of Ca+Coordinated electrical stimulusAdequate Amounts of ATPNeeded to:Maintain electroch
2、emical gradientsPropagate action potentialsPower muscle contractionAdequate Amounts of CalciumCalcium is glue that links electrical and mechanical events.Coordinated Electrical StimulationHeart capable of automaticityTwo types of myocardial tissueContractileConductiveImpulses travel through action p
3、otential superhighway.A.P. SuperHighwaySinoatrial nodeAtrioventricular nodeBundle of HisBundle BranchesFasciclesPurkinje NetworkElectrophysiologyTwo types of action potentialsFast potentialsFound in contractile tissueSlow potentialsFound in SA, AV node tissuesFast Potential-80-60-40-200+20RMP-80 to
4、90 mVPhase 1Phase 2Phase 3Phase 4controlled by Na+channels = “fast channels”Fast PotentialPhase 0: Na+ influx “fast sodium channels”Phase 1: K + effluxPhase 2: (Plateau) K + efflux AND Ca + + influxPhase 3: K+ effluxPhase 4: Resting Membrane PotentialCardiac Conduction CycleSlow Potential-80-60-40-2
5、00Phase 4Phase 3dependent upon Ca+ channels = “slow channels”Slow PotentialSelf-depolarizingResponsible for automaticityPhase 4 depolarizationslow sodium-calcium channelsleaky to sodiumPhase 3 repolarizationK+ effluxCardiac Pacemaker DominanceIntrinsic firing rates:SA = 60 100 AV = 45 60Purkinje = 1
6、5 - 45Cardiac PacemakersSA is primaryFaster depolarization rateFaster Ca+ leakOthers are backupsGraduated depolarization rateGraduated Ca+ leak ratePotential TermsAPDERPRRPrelative refractoryperiodeffective refractory periodaction potential durationDysrhythmia GenerationAbnormal genesisImbalance of
7、ANS stimuliPathologic phase 4 depolarizationEctopic fociDysrhythmia GenerationAbnormal conductionAnalogies:One way valveBuggies stuck in muddy roadsReentrant CircuitsWarning!All antidysrhythmics have arrythmogenic propertiesIn other words, they all can CAUSE dysrhythmias too!AHA Recommendation Class
8、ificationsDescribes weight of supporting evidence NOT mechanismClass IClass IIaClass IIb IndeterminantClass IIIView AHA definitionsVaughn-Williams ClassificationClass 1IaIbIcClass IIClass IIIClass IVMiscDescription of mechanism NOT evidenceClass I: Sodium Channel BlockersDecrease Na+ movement in pha
9、ses 0 and 4Decreases rate of propagation (conduction) via tissue with fast potential (Purkinje)Ignores those with slow potential (SA/AV)Indications: ventricular dysrhythmiasClass Ia AgentsSlow conduction through ventriclesDecrease repolarization rateWiden QRS and QT intervalsMay promote Torsades des
10、 Pointes!PDQ:procainamide (Pronestyl)disopyramide (Norpace)qunidine (Quinidex)Class Ib AgentsSlow conduction through ventriclesIncrease rate of repolarizationReduce automaticityEffective for ectopic fociMay have other usesLTMD:lidocaine (Xylocaine)tocainide (Tonocard)mexiletine (Mexitil)phenytoin (D
11、ilantin)Class Ic AgentsSlow conduction through ventricles, atria & conduction systemDecrease repolarization rateDecrease contractilityRare last chance drugflecainide (Tambocor)propafenone (Rythmol)Class II: Beta BlockersBeta1 receptors in heart attached to Ca+ channelsGradual Ca+ influx responsible
12、for automaticityBeta1 blockade decreases Ca+ influxEffects similar to Class IV (Ca+ channel blockers)Limited # approved for tachycardiasClass II: Beta Blockerspropranolol (Inderal)acebutolol (Sectral)esmolol (Brevibloc)Class III: Potassium Channel BlockersDecreases K+ efflux during repolarizationPro
13、longs repolarizationExtends effective refractory periodPrototype: bretyllium tosylate (Bretylol)Initial norepi discharge may cause temporary hypertension/tachycardiaSubsequent norepi depletion may cause hypotensionClass IV: Calcium Channel BlockersSimilar effect as blockersDecrease SA/AV automaticit
14、yDecrease AV conductivityUseful in breaking reentrant circuitPrime side effect: hypotension & bradycardiaverapamil (Calan)diltiazem (Cardizem)Note: nifedipine doesnt work on heartMisc. Agentsadenosine (Adenocard)Decreases Ca+ influx & increases K+ efflux via 2nd messenger pathwayHyperpolarization of
15、 membraneDecreased conduction velocity via slow potentialsNo effect on fast potentialsProfound side effects possible (but short-lived)Misc. AgentsCardiac Glycocidesdigoxin (Lanoxin)Inhibits NaKATP pumpIncreases intracellular Ca+via Na+-Ca+ exchange pumpIncreases contractilityDecreases AV conduction
16、velocityPharmacologyAntihypertensivesAntihypertensive Classesdiureticsbeta blockersangiotensin-converting enzyme (ACE) inhibitors calcium channel blockersvasodilatorsBlood Pressure = CO X PVRCardiac Output = SV x HRPVR = AfterloadBP = CO x PVRKey:CCB = calcium channel blockersCA Adrenergics = centra
17、l-acting adrenergicsACEis = angiotensin-converting enzyme inhibitorscardiac factorscirculating volumeheart ratecontractility1. Beta Blockers2. CCBs3. C.A. AdrenergicssaltaldosteroneACEisDiureticsBP = CO x PVRHormones1. vasodilators2. ACEIs3. CCBs Central Nervous System1. CA AdrenergicsPeripheral Sym
18、patheticReceptorsalpha beta1. alpha blockers 2. beta blockersLocal Acting1. Peripheral-Acting AdrenergicsAlpha1 BlockersStimulate alpha1 receptors - hypertensionBlock alpha1 receptors - hypotensiondoxazosin (Cardura)prazosin (Minipress)terazosin (Hytrin)Central Acting AdrenergicsStimulate alpha2 rec
19、eptors inhibit alpha1 stimulationhypotensionclonidine (Catapress)methyldopa (Aldomet)Peripheral Acting Adrenergicsreserpine (Serpalan)inhibits the release of NEdiminishes NE storesleads to hypotensionProminent side effect of depressionalso diminishes seratoninAdrenergic Side EffectsCommondry mouth,
20、drowsiness, sedation & constipationorthostatic hypotensionLess commonheadache, sleep disturbances, nausea, rash & palpitationsAngiotensin IACEAngiotensin II1. potent vasoconstrictor- increases BP2. stimulates Aldosterone- Na+ & H2OreabsorbtionACE Inhibitors .RAASRenin-Angiotensin Aldosterone SystemA
21、ngiotensin II = vasoconstrictorConstricts blood vessels & increases BPIncreases SVR or afterloadACE-I blocks these effects decreasing SVR & afterloadACE InhibitorsAldosterone secreted from adrenal glands cause sodium & water reabsorptionIncrease blood volumeIncrease preloadACE-I blocks this and decr
22、eases preloadAngiotensin Converting Enzyme Inhibitorscaptopril (Capoten)enalapril (Vasotec)lisinopril (Prinivil & Zestril)quinapril (Accupril)ramipril (Altace)benazepril (Lotensin)fosinopril (Monopril)Calcium Channel BlockersUsed for:AnginaTachycardiasHypertensionCCB Site of Actiondiltiazem & verapa
23、milnifedipine (and otherdihydropyridines)CCB Actiondiltiazem & verapamildecrease automaticity & conduction in SA & AV nodesdecrease myocardial contractilitydecreased smooth muscle tonedecreased PVRnifedipinedecreased smooth muscle tonedecreased PVRSide Effects of CCBsCardiovascularhypotension, palpi
24、tations & tachycardiaGastrointestinalconstipation & nauseaOtherrash, flushing & peripheral edemaCalcium Channel Blockersdiltiazem (Cardizem)verapamil (Calan, Isoptin)nifedipine (Procardia, Adalat)Diuretic Site of Action.loop of HenleproximaltubuleDistal tubuleCollecting ductMechanismWater follows Na
25、+20-25% of all Na+ is reabsorbed into the blood stream in the loop of Henle5-10% in distal tubule & 3% in collecting ductsIf it can not be absorbed it is excreted with the urine Blood volume = preload !Side Effects of Diureticselectrolyte losses Na+ & K+ fluid losses dehydrationmyalgiaN/V/Ddizziness
26、hyperglycemiaDiureticsThiazides:chlorothiazide (Diuril) & hydrochlorothiazide (HCTZ, HydroDIURIL)Loop Diureticsfurosemide (Lasix), bumetanide (Bumex)Potassium Sparing Diureticsspironolactone (Aldactone)Mechanism of VasodilatorsDirectly relaxes arteriole smooth muscleDecrease SVR = decrease afterload
27、 Side Effects of Vasodilatorshydralazine (Apresoline)Reflex tachycardiasodium nitroprusside (Nipride)Cyanide toxicity in renal failureCNS toxicity = agitation, hallucinations, etc.Vasodilatorsdiazoxide Hyperstathydralazine Apresolineminoxidil Lonitensodium Nitroprusside NipridePharmacologyDrugs Affe
28、cting HemostasisHemostasisReproduce figure 11-9, page 359 Sherwood Platelet AdhesionCoagulation CascadeReproduce following components of cascade:Prothrombin - thrombin Fibrinogen - fibrinPlasminogen - plasminPlatelet InhibitorsInhibit the aggregation of plateletsIndicated in progressing MI, TIA/CVAS
29、ide Effects: uncontrolled bleedingNo effect on existing thrombi AspirinInhibits COXArachidonic acid (COX) - TXA2 ( aggregation)GP IIB/IIIA InhibitorsGP IIb/IIIaInhibitorsFibrinogenGP IIb/IIIaReceptorGP IIB/IIIA Inhibitorsabciximab (ReoPro)eptifibitide (Integrilin)tirofiban (Aggrastat)AnticoagulantsI
30、nterrupt clotting cascade at various pointsNo effect on plateletsHeparin & LMW Heparin (Lovenox)warfarin (Coumadin)HeparinEndogenousReleased from mast cells/basophilsBinds with antithrombin IIIAntithrombin III binds with and inactivates excess thrombin to regionalize clotting activity.Most thrombin
31、(80-95%) captured in fibrin mesh.Antithrombin-heparin complex 1000X as effective as antithrombin III aloneHeparinMeasured in Units, not milligramsIndications:MI, PE, DVT, ischemic CVAAntidote for heparin OD: protamine.MOA: heparin is strongly negatively charged. Protamine is strongly positively char
32、ged. warfarin (Coumadin)Factors II, VII, IX and X all vitamin K dependent enzymesWarfarin competes with vitamin K in the synthesis of these enzymes.Depletes the reserves of clotting factors.Delayed onset (12 hours) due to existing factorsThrombolyticsDirectly break up clotsPromote natural thrombolys
33、isEnhance activation of plasminogenTime is Musclestreptokinase (Streptase)alteplase (tPA, Activase)anistreplase (Eminase)reteplase (Retevase)tenecteplase (TNKase)Occlusion MechanismtPA MechanismCholesterol MetabolismCholesterol important component in membranes and as hormone precursorSynthesized in liverHydroxymethylglutaryl coenzyme A reductase(HMG CoA reductase) dependantStored in tissues for latter useInsoluble in plasma (a type of lipid)Must have transport mechanismLipoproteinsLipids are surroun
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
- 6. 下載文件中如有侵權(quán)或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025-2030年中國餐飲設(shè)備市場發(fā)展趨勢規(guī)劃研究報告
- 2025-2030年中國鋼制車輪行業(yè)發(fā)展現(xiàn)狀及前景趨勢分析報告
- 2025-2030年中國采暖散熱器行業(yè)十三五規(guī)劃及發(fā)展前景分析報告
- 2025-2030年中國通信繼電器市場供需狀況及投資戰(zhàn)略研究報告
- 2025-2030年中國船舶涂料產(chǎn)業(yè)運營狀況與發(fā)展趨勢分析報告
- 2025-2030年中國聚酯多元醇行業(yè)市場現(xiàn)狀分析規(guī)劃研究報告
- 2025-2030年中國網(wǎng)絡(luò)借貸市場發(fā)展現(xiàn)狀及前景趨勢分析報告
- 2025-2030年中國精制棉市場運營現(xiàn)狀及投資前景規(guī)劃研究報告
- 2025-2030年中國眼視光行業(yè)發(fā)展趨勢規(guī)劃研究報告
- 【古鎮(zhèn)旅游發(fā)展研究國內(nèi)外文獻綜述3200字】
- SolidWorks全套入門教程
- 企業(yè)財務會計(第二版)高職PPT完整全套教學課件
- 3dsMax20223維動畫制作標準教程PPT完整版全套教學課件
- NXT上的PoP貼裝課件
- 2023-2024蘇教版小學數(shù)學5五年級下冊(全冊)教案設(shè)計
- 批評他人發(fā)言稿(通用12篇)
- 上海實驗學校幼升小測試題資料
- 一年級美術(shù)課后服務教案-1
- 重大疾病保險的疾病定義使用規(guī)范(2020年修訂版)-
- RB/T 040-2020病原微生物實驗室生物安全風險管理指南
評論
0/150
提交評論